MX2013007501A - Formulacion de isoxazolina topica localizada que comprende glucofurol. - Google Patents

Formulacion de isoxazolina topica localizada que comprende glucofurol.

Info

Publication number
MX2013007501A
MX2013007501A MX2013007501A MX2013007501A MX2013007501A MX 2013007501 A MX2013007501 A MX 2013007501A MX 2013007501 A MX2013007501 A MX 2013007501A MX 2013007501 A MX2013007501 A MX 2013007501A MX 2013007501 A MX2013007501 A MX 2013007501A
Authority
MX
Mexico
Prior art keywords
glycofurol
topical localized
formulation
localized isoxazoline
isoxazoline formulation
Prior art date
Application number
MX2013007501A
Other languages
English (en)
Other versions
MX348079B (es
Inventor
Stefan Fuchs
Anja Regina Heckeroth
Ramona Mueller
Heike Williams
Hartmut Zoller
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43920659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013007501(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2013007501A publication Critical patent/MX2013007501A/es
Publication of MX348079B publication Critical patent/MX348079B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención proporciona formulaciones tópicas localizadas que comprenden un compuesto de isoxazolina y un vehículo portador líquido farmacéuticamente o veterinariamente aceptable que comprende glucofurol y un método mejorado para controlar, y para prevenir la infestación parasitaria en animales.
MX2013007501A 2010-12-27 2011-12-22 Formulacion de isoxazolina topica localizada que comprende glucofurol. MX348079B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10197090 2010-12-27
US201161430241P 2011-01-06 2011-01-06
PCT/EP2011/073830 WO2012089623A1 (en) 2010-12-27 2011-12-22 Topical localized isoxazoline formulation comprising glycofurol

Publications (2)

Publication Number Publication Date
MX2013007501A true MX2013007501A (es) 2013-08-01
MX348079B MX348079B (es) 2017-05-25

Family

ID=43920659

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007501A MX348079B (es) 2010-12-27 2011-12-22 Formulacion de isoxazolina topica localizada que comprende glucofurol.

Country Status (18)

Country Link
US (2) US20130274302A1 (es)
EP (1) EP2658541B1 (es)
JP (3) JP2014506249A (es)
KR (2) KR101992589B1 (es)
CN (2) CN108125951A (es)
AU (1) AU2011351579B2 (es)
BR (1) BR112013015498A2 (es)
CA (1) CA2822853C (es)
DK (1) DK2658541T3 (es)
ES (1) ES2908254T3 (es)
HU (1) HUE058290T2 (es)
MX (1) MX348079B (es)
NZ (1) NZ611474A (es)
PL (1) PL2658541T3 (es)
PT (1) PT2658541T (es)
RU (1) RU2602189C2 (es)
WO (1) WO2012089623A1 (es)
ZA (1) ZA201304515B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101992589B1 (ko) * 2010-12-27 2019-06-24 인터벳 인터내셔널 비.브이. 글리코푸롤을 포함하는 국소 적용 이속사졸린 제제
CA2822839C (en) 2010-12-27 2020-12-29 Intervet International B.V. Topical localized isoxazoline formulation
DK3172964T3 (da) 2011-09-12 2020-11-30 Boehringer Ingelheim Animal Health Usa Inc Parasitiske sammensætninger indeholdende et isoxazolinaktivstof, fremgangsmåde og anvendelser deraf
EP3216448B8 (en) 2012-02-06 2019-06-05 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
JP6273252B2 (ja) * 2012-03-13 2018-01-31 バイエル・ニュージーランド・リミテッド 長時間作用型の組成物
CN105873925B (zh) 2013-11-01 2019-09-10 勃林格殷格翰动物保健美国公司 抗寄生物的和杀虫的异噁唑啉化合物
EP2875726A1 (fr) * 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
HUE066811T2 (hu) 2013-12-20 2024-09-28 Intervet Int Bv Izoxazolin kompozíciók és azok felhasználása parazitafertõzések megelõzésében és kezelésében állatokban
BR112016014216B1 (pt) 2013-12-20 2022-08-30 Intervet International B.V. Usos de um composto isoxazolina
ES2765405T3 (es) 2014-04-17 2020-06-09 Boehringer Ingelheim Animal Health Usa Inc Utilización de compuestos de malononitrilo para proteger animales de parásitos
EP3236960A1 (en) 2014-12-22 2017-11-01 Intervet International B.V. Use of isoxazoline compounds for treating demodicosis
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
KR102593069B1 (ko) 2015-04-08 2023-10-23 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 이속사졸린 활성제를 포함하는 서방형 주사 제형, 이의 방법 및 용도
ES2916216T3 (es) 2015-05-20 2022-06-29 Boehringer Ingelheim Animal Health Usa Inc Compuestos de depsipéptidos antihelmínticos
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
AU2017344097A1 (en) 2016-10-14 2019-05-02 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
JP2020530850A (ja) 2017-08-14 2020-10-29 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 殺有害生物および殺寄生生物ピラゾール−イソキサゾリン化合物
BR112020010291A2 (pt) * 2017-11-23 2020-11-17 Ceva Sante Animale composição contendo moxidectina para tratamento de infestações de parasitas
EP3820870A1 (en) 2018-07-09 2021-05-19 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
PE20220281A1 (es) 2019-03-19 2022-02-25 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos
KR20220004158A (ko) 2019-05-03 2022-01-11 인터벳 인터내셔널 비.브이. 주사가능한 제약 조성물 및 그의 용도
BR112022000767A2 (pt) 2019-07-16 2022-03-15 Donaghys Ltd Sistema de solvente transdérmico e métodos de uso
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
JP2023528822A (ja) 2020-05-29 2023-07-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性複素環式化合物
US20220201983A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal collar comprising isoxazoline compounds
US20240316045A1 (en) 2021-01-27 2024-09-26 Intervet Inc. Cyclopropylamide compounds against parasites in fish
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
US20230312207A1 (en) 2022-02-17 2023-10-05 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
GB8331037D0 (en) * 1983-11-21 1983-12-29 May & Baker Ltd Compositions of matter
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of "4-deoxy-" 4-epi-methylamino abramectin and insecticides containing them
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US20050192319A1 (en) 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
HUE032009T2 (en) * 2003-04-04 2017-09-28 Merial Inc Veterinary preparations for topical veterinary use
US20050142201A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for fabrication, uses and compositions of small spherical particles of hGH prepared by controlled phase separation
DK1731512T3 (en) 2004-03-05 2015-01-05 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide AND INSTRUMENTS FOR COMBATING HARMFUL ORGANISMS
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX368680B (es) 2007-06-27 2019-10-11 Du Pont Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga.
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
FR2925337B1 (fr) * 2007-12-21 2010-01-15 Virbac Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
WO2010079077A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
BRPI0923009B1 (pt) 2008-12-19 2018-07-17 Elanco Tiergesundheit Ag compostos de isoxazolina, composição para o controle de parasitas e uso de compostos de isoxazolina para o preparo de composição para o controle de parasitas
WO2010128095A1 (en) 2009-05-07 2010-11-11 Novartis Ag Ectoparasiticidal compositions
EA201401222A1 (ru) 2009-12-17 2015-10-30 Мериал Лимитед Противопаразитарные дигидроазоловые соединения и содержащие их композиции
DK178277B1 (da) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
KR101992589B1 (ko) * 2010-12-27 2019-06-24 인터벳 인터내셔널 비.브이. 글리코푸롤을 포함하는 국소 적용 이속사졸린 제제
CA2822839C (en) * 2010-12-27 2020-12-29 Intervet International B.V. Topical localized isoxazoline formulation
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Also Published As

Publication number Publication date
WO2012089623A1 (en) 2012-07-05
JP6539384B2 (ja) 2019-07-03
US20130274302A1 (en) 2013-10-17
PT2658541T (pt) 2022-03-11
EP2658541B1 (en) 2022-01-26
AU2011351579A1 (en) 2013-06-20
PL2658541T3 (pl) 2022-04-04
EP2658541A1 (en) 2013-11-06
RU2013135415A (ru) 2015-02-10
BR112013015498A2 (pt) 2016-11-01
CN103260620A (zh) 2013-08-21
DK2658541T3 (da) 2022-04-04
AU2011351579B2 (en) 2016-04-21
KR101920476B1 (ko) 2018-11-21
ZA201304515B (en) 2014-03-26
KR20130130762A (ko) 2013-12-02
JP2014506249A (ja) 2014-03-13
US20150011596A1 (en) 2015-01-08
KR20180125618A (ko) 2018-11-23
JP2018154657A (ja) 2018-10-04
RU2602189C2 (ru) 2016-11-10
NZ611474A (en) 2015-08-28
ES2908254T3 (es) 2022-04-28
KR101992589B1 (ko) 2019-06-24
HUE058290T2 (hu) 2022-07-28
CA2822853C (en) 2021-05-11
CA2822853A1 (en) 2012-07-05
JP2016216489A (ja) 2016-12-22
MX348079B (es) 2017-05-25
JP6357508B2 (ja) 2018-07-11
CN108125951A (zh) 2018-06-08

Similar Documents

Publication Publication Date Title
MX348079B (es) Formulacion de isoxazolina topica localizada que comprende glucofurol.
MX2013007500A (es) Formulacion de isoxazolina topica localizada.
HUS2100024I1 (hu) Izoxazolint tartalmazó parazita-ellenes készítmények, ezek elõállítása és alkalmazása
HRP20190164T1 (hr) Paraziticidni oralni veterinarski sastavi koji obuhvaćaju djelatne tvari sa sustavnim djelovanjem, i načini njihove primjene
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
HK1145803A1 (en) Devices, formulations, and methods for delivery of multiple beneficial agents
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
MX346936B (es) Metodo, composiciones y empaque para limpieza del intestino.
WO2013003827A3 (en) Macrogol 15 hydroxystearate formulations
MX2012008799A (es) Formulaciones antiparasitarias topicas.
MX2019011837A (es) Formulacion de isoxazolina topica localizada que comprende glicofurol.
WO2012095388A3 (en) Compounds for treatment of feline leukemia in felidae
UA46282U (ru) Способ индукции полиовуляции у коров-доноров

Legal Events

Date Code Title Description
FG Grant or registration